Medical Services International to Begin Shipping to Greece

EDMONTON, Alberta, Dec. 19  /PRNewswire-FirstCall/ -- Medical Services International Inc. (OTC:MSITF) is pleased to announce that it has received orders for its VScan HIV, Hepatitis C, and Tuberculosis (TB) test kits from Greece. The initial orders will be shipped in January 2007. It has been indicated that there will be follow up orders in excess of 500,000 kits over the next 6 months.

The VScan test kits have done very well in testing in Europe. As a result of the independent test results obtained significant interest from Europe is being generated by the test kits. The Company expects 2007 to be a significant growth year.

About VScan

The VScan rapid test kit is a single use, disposable, accurate, cost effective, easy to use, test for the screening of HIV 1&2, Hepatitis B&C, Tuberculosis (TB), Dengue Fever, West Nile, Syphilis, Malaria and Prostate Cancer. The kits cannot be sold in Canada.

Medical Services International Inc. trades in the United States on the NQB Pinksheets under the symbol "MSITF". For further information, please contact Robert Talbot at [phone] or http://www.medicalservicesintl.com/ or http://www.minerva-biotech.com/ .

NOTE: Certain statements in this press release are "forward-looking statements" within the meaning of the Private Securities Act of 1995. Such statements involve known and unknown risks, uncertainties and other factors that may cause results to differ materially. Such risks, uncertainties and other factors include but are not limited to new economic conditions, risk in product development, market acceptance of new products and continuing product demand, level of competition and other factors described in Company reports and other filings with regulatory bodies. 

DATASOURCE: Medical Services International Inc.



CONTACT:  Robert Talbot of Medical Services International Inc.,

[phone]



Web site:  http://www.medicalservicesintl.com/

http://www.minerva-biotech.com/ 

Copyright